NR566 Advanced Pharmacology Care of the Family Midterm Review LATEST 2021 – 2022 Chamberlain College

Examination For NR566 Advanced Pharmacology Care of the Family Midterm Review LATEST 2021 – 2022 Chamberlain College

NR 566 / NR566 Advanced Pharmacology Care of the Family Midterm Review| LATEST 2021 /2022 | Chamberlain College 1. Find out how to measure therapeutic impact of HIV remedy – RNA LEVELS o baseline o 2-4 weeks, no later than 8 weeks o each 4-8 weeks till suppressed o after suppressed each 3-4 months – Lengthy-time period virologic suppression x2 years o each 6 months – any change in standing = chemo/steroids o each 3 months 2. Protease Inhibitor (PIs) Lopinavir – excessive danger sufferers – ORAL resolution: Contraindicated for full-time period infants (till 14 days after start) and untimely (till 14 days after due date) o cardiac illness o Hx delay QT 3. Protease Inhibitor (PIs) Lopinavir – Lifespan issues – Kids: Secure after 14 days outdated – Being pregnant: accepted w/ increased dangers 4. Protease Inhibitor (PIs) Lopinavir/ritonavir – opposed results – – QT prolongation 5. Protease Inhibitor (PIs) Saquinavir – Lifespan issues – Kids o Not recognized as secure/environment friendly in youngsters youthful than 16 – Being pregnant o Most secure PI for being pregnant – HIV therapy is advisable in being pregnant 6. Protease Inhibitor (PIs) Saquinavir – opposed reactions – – QT prolongation 7. Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTIs). Didanosine (ddI) – excessive danger affected person – Improve danger of pancreatitis with alcohol use, pancreatitis, and IV pentamide 8. Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTIs). Didanosine (ddI) – Lifespan issues – Kids o accepted in 6 years + weighing 20kg – Being pregnant o Much less danger 9. Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTIs). Zidovudine – Lifespan consideration – Kids o neonates – Being pregnant o elevated danger 10. Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTIs): Zidovudine – excessive danger sufferers – Hx of o granulocytosis o low H&H o low vit B12 o low folic acid o present use of meds that trigger myelosuppe 11. Find out how to measure therapeutic impact of HIV remedy – CD4 counts o w/ suppressed RNA ranges = improve CD4 ranges – Verify ranges o baseline o at 3 month mark o throughout 1st 2 years each 3-6 months throughout remedy o lengthy-time period suppression – CD4 <300 = each 3-6 months